On Rutgers Giving Day, a 24-hour fundraising event, Rutgers Global Health Institute raised $25,446 for the Botswana-Rutgers Partnership for Health.
A grant from the New Jersey Department of Health is supporting the expansion of Rutgers Global Health Institute’s Equitable Recovery program. Efforts are underway to help underserved communities in Essex, Mercer, and Middlesex counties offer residents accessible COVID-19 vaccination and testing.
Botswana Cancer Initiative Leader Discusses Parallels with AIDS and Progress on Oncology Workforce Training
Refeletswe Lebelonyane is a physician, public health professional, and program manager for the Botswana-Rutgers Partnership for Health. In this Q&A, she provides updates on cancer care and prevention efforts in Botswana and reflects on her past experiences confronting HIV/AIDS in the African country.
COVID-19 testing and vaccination clinics at the New Brunswick Performing Arts Center, where the ballet is a member company, are part of Rutgers Global Health Institute’s Equitable Recovery program. The clinics, which are open to the public, helped the ballet’s dancers safely return to the studio and stage.
Rutgers students in clinical and non-clinical programs of study can volunteer to help with operations at the university’s on-campus vaccination clinic at the Ernest Mario School of Pharmacy in Piscataway.
In underserved neighborhoods in the city’s South and West wards, small business owners and local leaders are voices for their communities. Their input and guidance inform the rollout of initiatives to improve vaccination rates and help communities build resilience—a top goal of the Equitable Recovery for New Jersey’s Small Businesses program.
In an episode of the Bloomberg Balance of Power podcast titled “Responding to the Omicron Variant,” Rutgers Global Health Institute director Richard Marlink talks about vaccination uptake, protecting older people, mask mandates, frustrations with government officials, travel bans, and holiday gatherings.
University experts in infectious disease, epidemiology, pediatrics, and global health share insights related to Omicron, which the World Health Organization has labeled a variant of concern.
Rutgers faculty member Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses questions about the vaccine rollout for this age group.
Co-presidents Brooke Margolin, a public health major, and Laura Palm, a musician with an M.D. degree, talk about the effects of COVID-19 on Rutgers students’ lives, thoughts, and future plans.